Periodontal diseases. Periodontal diseases
Conditions
Interventions
Intervention 1: Group A: perform daily mouthwashes twice a day with the solution containing 10 ml of 0.05 cetylpyridinium, (Vi-one, Rojin, Cosmetic-Lab, Kurdistan -Iran). Intervention 2: Group B: us
Treatment - Drugs
Group A: perform daily mouthwashes twice a day with the solution containing 10 ml of 0.05 cetylpyridinium, (Vi-one, Rojin, Cosmetic-Lab, Kurdistan -Iran).
Group B: use daily mouthwashes twice a day with 10ml of the non- alcoholic chlorhexidine (Kin Labratories, Spain).
Sponsors
Deputy of Research Council Of Dental Branch, Islamic Azad University of Tehran
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: adult patients, older than 18 years old, systemically healthy, and having at least 20 teeth. Exclusion criteria: patients with cavitated caries, no periodontal pockets larger than 4 mm, orthodontic appliances or removable prostheses, allergies to cetylpyridinium or CHX, use of antibiotics and anti-inflammatory drugs in the past 3 months that might alter normal gingival health, oral prophylaxis outside of study; use of oral chlorhexidine products or participation in an oral rinse study within 3 months prior to baseline examination, pregnancy or nursing, smoking.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of pocket depth. Timepoint: One month. Method of measurement: Periodontal pobe. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of plaque index. Timepoint: One month. Method of measurement: Plaque Index (O’Leary).;Reduction of bleeding on probing. Timepoint: One month. Method of measurement: Bleeding index (Carterand Barnes). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmirhossein Farahmand
Dental Branch, Islamic Azad University of Tehran
Outcome results
None listed